Cambridge Financial Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$5.95M |
| 2 |
Starbucks
SBUX
|
+$5.64M |
| 3 |
Monster Beverage
MNST
|
+$5.39M |
| 4 |
Walmart Inc
WMT
|
+$301K |
| 5 |
Oneok
OKE
|
+$201K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.62M |
| 2 |
FedEx
FDX
|
+$6.13M |
| 3 |
RTN
Raytheon Company
RTN
|
+$5.98M |
| 4 |
UnitedHealth
UNH
|
+$784K |
| 5 |
AET
Aetna Inc
AET
|
+$762K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.85% |
| 2 | Consumer Staples | 19.2% |
| 3 | Consumer Discretionary | 14.54% |
| 4 | Industrials | 12.88% |
| 5 | Technology | 9.76% |
Similar funds
Cambridge Financial Group's Q3 2015 Portfolio in Review
As of Q3 2015, Cambridge Financial Group held 33 positions worth $167M, down 11% from $188M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Cambridge Financial Group withdrew a net $7.98M in Q3 2015, closing 3 positions and reducing 25 holdings. Its most notable exit was Biogen, an estimated $6.62M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Cambridge Financial Group opened a new position in Eli Lilly worth $5.9M.
- Cambridge Financial Group's largest Q3 2015 buy was Eli Lilly: 70,451 shares worth $5.9M.
- Cambridge Financial Group added most to Walmart Inc in Q3 2015, an estimated $301K increase.
- Cambridge Financial Group's biggest Q3 2015 reduction was UnitedHealth, cutting an estimated $784K.
- Cambridge Financial Group fully exited Biogen in Q3 2015, selling an estimated $6.62M.
- Cambridge Financial Group's ten largest holdings make up 37% of its $167M portfolio in Q3 2015.
- Cambridge Financial Group opened 3 new positions and closed 3 in Q3 2015.
- Cambridge Financial Group's portfolio value fell 11% quarter-over-quarter to $167M.
Based on Cambridge Financial Group's 13F filing for Q3 2015, filed 12 Nov 2015.